Compare Precision System Science Co., Ltd. with Similar Stocks
Dashboard
1
With a growth in Net Profit of 1752.63%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 7 consecutive quarters
- ROCE(HY) Highest at 3.49%
- INVENTORY TURNOVER RATIO(HY) Highest at 2.27 times
- OPERATING PROFIT MARGIN(Q) Highest at 8.46 %
2
With ROE of 1.49%, it has a risky valuation with a 1.68 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 6,087 Million (Micro Cap)
113.00
NA
0.00%
-0.01
4.16%
1.56
Revenue and Profits:
Net Sales:
1,244 Million
(Quarterly Results - Mar 2026)
Net Profit:
140 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.43%
0%
-13.43%
6 Months
2.75%
0%
2.75%
1 Year
-6.5%
0%
-6.5%
2 Years
-1.58%
0%
-1.58%
3 Years
-46.42%
0%
-46.42%
4 Years
-59.61%
0%
-59.61%
5 Years
-77.06%
0%
-77.06%
Precision System Science Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-7.83%
EBIT Growth (5y)
-32.75%
EBIT to Interest (avg)
1.57
Debt to EBITDA (avg)
1.94
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.87
Tax Ratio
0.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.19%
ROE (avg)
2.77%
Valuation key factors
Factor
Value
P/E Ratio
113
Industry P/E
Price to Book Value
1.68
EV to EBIT
84.19
EV to EBITDA
21.30
EV to Capital Employed
1.71
EV to Sales
1.25
PEG Ratio
1.04
Dividend Yield
NA
ROCE (Latest)
2.03%
ROE (Latest)
1.49%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
1,244.10
1,217.30
2.20%
Operating Profit (PBDIT) excl Other Income
105.20
76.00
38.42%
Interest
4.70
4.30
9.30%
Exceptional Items
0.00
-1.30
100.00%
Consolidate Net Profit
139.70
7.50
1,762.67%
Operating Profit Margin (Excl OI)
39.90%
23.70%
1.62%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.20% vs -7.58% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 1,762.67% vs -86.21% in Dec 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
4,692.60
3,980.00
17.90%
Operating Profit (PBDIT) excl Other Income
116.60
-547.20
121.31%
Interest
20.50
31.60
-35.13%
Exceptional Items
-113.10
-83.30
-35.77%
Consolidate Net Profit
-253.10
-1,121.50
77.43%
Operating Profit Margin (Excl OI)
-25.90%
-240.30%
21.44%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 17.90% vs -24.60% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 77.43% vs 15.31% in Jun 2024
About Precision System Science Co., Ltd. 
Precision System Science Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






